In:
International Journal of Cancer, Wiley, Vol. 136, No. 8 ( 2015-04-15), p. 1957-1966
Abstract:
What's new? Past studies have linked a low lymph node count in cancer resections with adverse outcome in colorectal cancer. It remains unclear however if a low lymph node number is a true biological risk factor justifying the international guideline to administer adjuvant chemotherapy in stage II colorectal cancers with fewer than 12 assessed lymph nodes, or if the observed association is due to false nodal‐negative staging by inadequate assessment. This study shows that a lymph node count 〈 12 has no prognostic impact when examination follows current quality standards, questioning the 12‐node cutoff for risk assessment and adjuvant therapy decision‐making in colorectal cancer.
Type of Medium:
Online Resource
ISSN:
0020-7136
,
1097-0215
Language:
English
Publisher:
Wiley
Publication Date:
2015
detail.hit.zdb_id:
218257-9
detail.hit.zdb_id:
1474822-8
Permalink